Sildenafil after cardiac arrest and infarction; an experimental rat model

Scandinavian Cardiovascular Journal

Volumn 47, Issue 1, 2013, Pages 58-64

  Mennander, Ari A ^a   Vuohelainen, Vilma ^a   Aanismaa, Riikka S ^a   Narkilahti, Susanna ^a   Paavonen, Timo ^a   Tarkka, Matti ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cardiac arrest; Infarction; Ischemia reperfusion; Rat; Sildenafil

Indexed keywords

AQUAPORIN 7; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; SILDENAFIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART ARREST; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; RESUSCITATION;

ANIMALS; AQUAPORINS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; HEART ARREST; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; INJECTIONS, SUBCUTANEOUS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; PURINES; RATS; RATS, INBRED F344; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SULFONES; TIME FACTORS; VASODILATOR AGENTS;

EID: 84872520223     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.3109/14017431.2012.732235     Document Type: Article

References (19)

1. Neumar RW, N olan J P, A drie C, A ibiki M, B erg R A, B ö ttiger BW, et al. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation. 2008 ; 118: 2452-83.
2. Liu Z, Vuohelainen V, Tarkka M, Tenhunen J, Lappalainen R S, Narkilahti S, et al. Glutamate release predicts ongoing myocardial ischemia of rat hearts. Scand J Clin Lab Invest. 2010 ; 70: 217-24.
3. Vuohelainen V, R aitoharju E, L evula M, L ehtimaki T, Pelto-Huikko M, Honkanen T, et al. Myocardial infarction induces early increased remote ADAM8 expression of rat hearts after cardiac arrest. Scand J Clin Lab Invest. 2011 ; 71: 553-62.
4. Suzuki K, M urtuza B, S molenski RT, S uzuki N, - acoub MH. Development of an in vivo ischemia-reperfusion model in heterotopically transplanted rat hearts. Transplantation. 2002 ; 73: 1398-402.
5. Wu D, B assuk J, A rias J, K urlansky P, L ozano H, L amas G, et al. Different roles of nitric oxide synthase isoforms in cardiopulmonary resuscitation in pigs. Resuscitation. 2007 ; 73: 144-53.
6. Berges A, V an Nassauw L, T immermans J P, V rints C. R ole of nitric oxide during coronary endothelial dysfunction after myocardial infarction. Eur J Pharmacol. 2005 ; 516: 60-70.
7. Choi DE, Jeong JY, L im BJ, Chung S, C hang YK, L ee SJ, et al. Pretreatment of sildenafi l attenuates ischemia-reperfusion renal injury in rats. Am J Physiol Renal Physiol. 2009 ; 297: F362-70.
8. Loganathan S, R adovits T, H irschberg K, K orkmaz S, Barnucz E, Karck M, et al. Effects of selective phosphodiesterase-5-inhibition on myocardial contractility and reperfusion injury after heart transplantation. Transplantation. 2008 ; 86: 1414-8.
9. Botha P, M acGowan GA, D ark JH. S ildenafi l citrate augments myocardial protection in heart transplantation. Transplantation. 2010 ; 89: 169-77.
10. Elrod JW, G reer JJ, L efer DJ. S ildenafi l-mediated acute cardioprotection is independent of the NO/cGMP pathway. Am J Physiol Heart Circ Physiol. 2007 ; 292: H342-7.
11. S alloum F, - in C, X i L, K ukreja R C. S ildenafi l induces delayed preconditioning through inducible nitric oxide synthasedependent pathway in mouse heart. Circ Res. 2003 ; 92: 595-7.
12. Fisher P W, S alloum F, D as A, H yder H, K ukreja R C. Phosphodiesterase-5 inhibition with sildenafi l attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity. Circulation. 2005 ; 111: 1601-10.
13. Ricci D, M ennander AA, M iyagi N, R ao V P, T azelaar HD, Classic K, et al. Prolonged cardiac allograft survival using iodine 131 after human sodium iodide symporter gene transfer in a rat model. Transplant Proc. 2010; 42: 1888-94.
14. Livak KJ, S chmittgen TD. A nalysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods. 2001 ; 25: 402-8.
15. Zhang J, K napton A, L ipshultz SE, W eaver JL, H erman EH. Isoproterenol-induced cardiotoxicity in Sprague-Dawley rats: correlation of reversible and irreversible myocardial injury with release of cardiac Troponin T and roles of iNOS in myocardial injury. Toxicol Pathol. 2008 ; 36: 277-88.
16. Das A, X i L, K ukreja RC. P hosphodiesterase-5 inhibitor sildenafi l preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling. J Biol Chem. 2005 ; 280: 12944-55.
17. Felaco M, Grilli A, Gorbunov N, Di Napoli P, De Lutiis MA, Di Giulio C, et al. Endothelial NOS expression and ischemia-reperfusion in isolated working rat heart from hypoxic and hyperoxic conditions. Biochim Biophys Acta. 2000 ; 1524: 203-11.
18. Desrois M, D urrans A, C aus T, L an C, C larke K, C ozzone PJ, et al. Modulation of the NO pathway during short or prolonged blood reperfusion following ischaemia in a heterotopic rat heart transplantation model. Transplant Proc. 2004; 36: 1280-2.
19. Hibuse T, M aeda N, N akatsuji H, T ochino Y, F ujita K, K ihara S, et al. The heart requires glycerol as an energy substrate through aquaporin 7, a glycerol facilitator. Cardiovasc Res. 2009 ; 83: 34-41.